Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region

Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region

Introduction. Hepatitis D (delta, 5) is caused by an RNA virus (hepatitis D virus, HDV) from genus Deltavirus, and is the most severe and difficult to treat disease among both viral hepatitis and infectious diseases in general. The development of HDV infection in the host organism is possible only i...

Full description

Bibliographic Details
Main Authors:	O. V. Isaeva, L. Yu. Il'chenko, A. A. Saryglar, A. A. Karlsen, K. K. Kyuregyan, M. I. Mikhailov
Format:	Article
Language:	English
Published:	Central Research Institute for Epidemiology 2021-03-01
Series:	Вопросы вирусологии
Subjects:	hepatitis d virus (hdv) chronic viral hepatitis d liver cirrhosis clinical and biochemical parameters, republic of tuva
Online Access:	https://virusjour.crie.ru/jour/article/viewFile/480/303

Similar Items

Animal delta-like viruses (Kolmioviridae: Deltavirus) and the origin of the human hepatitis D virus (HDV)
by: O. V. Isaeva, et al.
Published: (2021-11-01)

An update on the prevalence of viral hepatitis B and C among patients attending at tertiary hospital in South India
by: Aleem Ahmed Khan
Published: (2018-01-01)

Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
by: Romina Salpini, et al.
Published: (2024-01-01)

An overview of Triple infection with Hepatitis B, C and D viruses
by: Kanwal Hifza, et al.
Published: (2011-07-01)

Is Slovakia Almost a Hepatitis D Free Country?
by: Pavol Kristian, et al.
Published: (2023-08-01)

Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control
by: Cheng Kao, et al.
Published: (2021-08-01)

Characterization of hepatitis B and delta coinfection in Israel
by: Rachel Shirazi, et al.
Published: (2018-02-01)

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022Key points
by: Pietro Lampertico, et al.
Published: (2023-09-01)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
by: Adriana Palom, et al.
Published: (2022-10-01)

Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification
by: Antonella Olivero, et al.
Published: (2022-03-01)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
by: Caterina Sagnelli, et al.
Published: (2021-02-01)

Management of Delta Hepatitis 45 Years after the Discovery of HDV
by: Stefano Brillanti
Published: (2022-03-01)

Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community
by: Mariana Pinheiro Alves Vasconcelos, et al.
Published: (2024-01-01)

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
by: Mathias Jachs, et al.
Published: (2023-08-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)

Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan
by: Perveen Shadab, et al.
Published: (2012-08-01)

Prevalence of anti HDV in HBV carriers in Babol during 2000-02
by: MR Hassanjani Roshan, et al.
Published: (2004-01-01)

Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
by: A V Yagoda, et al.
Published: (2004-08-01)

Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections
by: Grace Sanghee Lee, et al.
Published: (2023-07-01)

Epidemiology Pattern, Prevalent Genotype Distribution, Fighting Stigma and Control Options for Hepatitis D in Bulgaria and Other European Countries
by: Denitsa Todorova Tsaneva-Damyanova, et al.
Published: (2023-04-01)

PHENOTYPE AND FUNCTIONS OF DENDRITIC CELLS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: O. Yu. Leplina, et al.
Published: (2014-07-01)

Seroprevalence of viral hepatitis B and C in two populations: blood donors and patients with suspected hepatic cirrhosis in Kwilu province, Democratic Republic of Congo
by: Junior Mudji, et al.
Published: (2021-09-01)

Chronic viral hepatitis D - the current state of a problem.
by: Aliya Konysbekova
Published: (2017-03-01)

A new publication on the history of Tuva (about the book by Z. Y. Dorzhu and O. Y. Irgit Рolitical repressions in the Tuva People’s Republic (1921–1944) – Novosibirsk, 2023)
by: S. A. Papkov
Published: (2023-12-01)

Serological detection of hepatitis B and D virus co-infection among patients attending a tertiary health facility at Maiduguri, Nigeria
by: Babajide B. Ajayi, et al.
Published: (2021-02-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

PREVALENCE OF MARKERS OF ENTERAL VIRAL HEPATITIS AMONG MIGRANT WORKERS ARRIVING IN RUSSIAN FEDERATION
by: S. D. Alsalikh, et al.
Published: (2017-06-01)

A Mathematical Model for Early HBV and -HDV Kinetics during Anti-HDV Treatment
by: Rami Zakh, et al.
Published: (2021-12-01)

High Prevalence of Hepatitis Delta Virus among Persons Who Inject Drugs, Vietnam
by: Naomi Hall, et al.
Published: (2015-03-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

ORGANIC MATTER AND GEOCHEMISTRY OF MIDDLE JURASSIC COALS OF THE MEZHEGEY DEPOSIT (ULUG-KHEM BASIN, TUVA)
by: Solangy A. Ondar, et al.
Published: (2022-11-01)

Universal Single-Dose Vaccination against Hepatitis A in Children in a Region of High Endemicity
by: Mikhail I. Mikhailov, et al.
Published: (2020-12-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
by: Eirini D. Tseligka, et al.
Published: (2021-04-01)

Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States
by: Ilona Argirion, et al.
Published: (2023-03-01)

Clinical and morphological case of developing liver cirrhosis associated with viral hepatitis in a young patient
by: O. V. Vorobeva, et al.
Published: (2021-09-01)

EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2017-01-01)

Contemporary strategy to control viral hepatitis A in the Russian Federation
by: M. I. Mikhailov, et al.
Published: (2021-05-01)

Belgorod region – the territory endemic for hepatitis E
by: K. K. Kyuregyan, et al.
Published: (2019-12-01)